nvmi (1)

Admin

Stocks With Growth Potential

eMagin (EMAN #4), which over the past few months has bounced on and off our rankings, sells high-resolution OLED (organic light emitting diode) microdisplays for military, industrial, medical and consumer applications. Click here to read our November 22 profile.



Onyx Pharma (ONXX #16) is a biopharmaceutical company with a focus on cancer therapies. It currently has one product approved by the FDA and on the market: Nexavar. This drug, which was co-developed with Bayer Pharma, is currently approved for the treatment of liver cancer and advanced kidney cancer. Nexavar is currently approved in more than 95 countries for the treatment of advanced kidney cancer and in more than 90 countries for the treatment of liver cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of other types of tumors.

Beyond Nexavar, Onyx has a development pipeline of anti-cancer compounds at various stages of clinical testing, most notably carfilzomib, a next-generation p

Read More, Comment and Share......

We welcome you to post a blog entry, oped or share your daily reading with us as long as it is relevant to the topic of investing and not an attempt to sell a product, proprietary strategy, platform or other service. Please provide links to any research data and if re-posting other articles, give credit where credit is due providing a back link to the original site.

300 words minimum per post. You may also sort by category or search by topic. Don't forget to comment and please "share" via Facebook, Twitter and Google+. If you have any questions, please contact us.

FOLLOW STOCKBUZ

__________________

This is a member-supported site. Please donate when you can to help pay the rent. Thank you!

Stay Informed. Sign up for the FREE StockBuz eNewsletter

________________

Investing involves substantial risk. All content is subject to StockBuz disclaimer.

Create Income With Option Spreads

All content on StockBuz.net is subject to disclaimer and Terms of Service